What is biological half-life?
Biological half-life is the time required for half of a substance to be eliminated from the body due to biological processes such as metabolism and excretion. Unlike physical half-life, which depends on nuclear decay, biological half-life reflects how the body handles a radiopharmaceutical.
Biological half-life is the time required for half of a radiopharmaceutical to be cleared from the body by physiological processes, independent of radioactive decay.
Biological half-life varies depending on the organ system involved, the chemical properties of the tracer, and patient-specific factors such as renal or hepatic function. It is not an intrinsic property of the radionuclide itself, but of the compound and its physiological behaviour.
In nuclear medicine, biological half-life determines how long a radiopharmaceutical remains within a particular tissue or organ.
Understanding the physics
After administration, a radiopharmaceutical distributes within the body according to its biochemical properties. It may bind to specific tissues, undergo metabolism, or be excreted through the kidneys, liver, or other pathways.
The rate at which the body clears the compound determines its biological half-life. For example, a tracer rapidly excreted by the kidneys will have a short biological half-life in blood and soft tissues. A tracer that binds strongly within bone or myocardium may have a longer biological half-life in those tissues.
Biological clearance follows approximately exponential behaviour, similar to radioactive decay, but the mechanism is entirely different. Clearance depends on physiological processes rather than nuclear instability.
When a radiopharmaceutical is administered, two independent processes occur:
Radioactive decay, governed by nuclear physics (physical half-life).
Biological elimination, governed by physiology (biological half-life).
Importantly, biological half-life and physical half-life operate independently. A radionuclide may have a long physical half-life but a short biological half-life if it is rapidly excreted. Conversely, it may remain in tissue long after much of the radioactivity has decayed.
These two processes combine to produce the effective half-life, which determines how long radioactivity actually persists within the body.
Where this matters clinically
Biological half-life influences both image timing and radiation dose. Rapid biological clearance can reduce radiation exposure but may also reduce image quality if insufficient tracer remains in target tissues. Understanding biological half-life helps optimise imaging protocols and interpret tracer kinetics.